Search Results - "Yoshikawa, Yukitaka"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Mechanisms of the hepatoprotective effects of tamoxifen against drug-induced and chemical-induced acute liver injuries by Yoshikawa, Yukitaka, Miyashita, Taishi, Higuchi, Satonori, Tsuneyama, Koichi, Endo, Shinya, Tsukui, Tohru, Toyoda, Yasuyuki, Fukami, Tatsuki, Nakajima, Miki, Yokoi, Tsuyoshi

    Published in Toxicology and applied pharmacology (01-10-2012)
    “…Although estrogen receptor (ER)α agonists, such as estradiol and ethinylestradiol (EE2), cause cholestasis in mice, they also reduce the degree of liver injury…”
    Get full text
    Journal Article
  2. 2

    Establishment of knockdown of superoxide dismutase 2 and expression of CYP3A4 cell system to evaluate drug-induced cytotoxicity by Yoshikawa, Yukitaka, Hosomi, Hiroko, Fukami, Tatsuki, Nakajima, Miki, Yokoi, Tsuyoshi

    Published in Toxicology in vitro (01-09-2009)
    “…Drug-induced hepatotoxicity is a major problem in drug development, and oxidative stress is known as one of the causes. Superoxide dismutases (SODs) are…”
    Get full text
    Journal Article
  3. 3

    Knockdown of superoxide dismutase 2 enhances acetaminophen-induced hepatotoxicity in rat by Yoshikawa, Yukitaka, Morita, Mayu, Hosomi, Hiroko, Tsuneyama, Koichi, Fukami, Tatsuki, Nakajima, Miki, Yokoi, Tsuyoshi

    Published in Toxicology (Amsterdam) (01-10-2009)
    “…Abstract Drug-induced hepatotoxicity is a major problem in drug development, and oxidative stress is known as one of the causes. Superoxide dismutases (SODs)…”
    Get full text
    Journal Article
  4. 4

    Chimeric Mice With Humanized Livers Demonstrate Human-Specific Hepatotoxicity Caused by a Therapeutic Antibody Against TRAIL-Receptor 2/Death Receptor 5 by Nihira, Kaito, Nan-ya, Ken-ichiro, Kakuni, Masakazu, Ono, Yoko, Yoshikawa, Yukitaka, Ota, Toshio, Hiura, Masanori, Yoshinari, Kouichi

    Published in Toxicological sciences (01-01-2019)
    “…Abstract The activation of tumor necrosis factor (TNF)-related apoptosis-inducing ligand receptor 2 (TRAIL-R2)/death receptor 5 (DR5) induces apoptosis in…”
    Get full text
    Journal Article
  5. 5

    Effect of antigen-dependent clearance on pharmacokinetics of anti-heparin-binding EGF-like growth factor (HB-EGF) monoclonal antibody by Kasai, Noriyuki, Yoshikawa, Yukitaka, Enokizono, Junichi

    Published in mAbs (01-09-2014)
    “…Heparin-binding EGF-like growth factor (HB-EGF) is a member of the EGF family and is an important therapeutic target in some types of human cancers. KM3566 is…”
    Get full text
    Journal Article
  6. 6

    IL-4 mediates dicloxacillin-induced liver injury in mice by Higuchi, Satonori, Kobayashi, Masanori, Yoshikawa, Yukitaka, Tsuneyama, Koichi, Fukami, Tatsuki, Nakajima, Miki, Yokoi, Tsuyoshi

    Published in Toxicology letters (05-02-2011)
    “…Drug-induced liver injury (DILI) is a major problem in drug development and clinical drug therapy. In most cases, the mechanisms are still unknown. It is…”
    Get full text
    Journal Article
  7. 7

    An in vitro drug-induced hepatotoxicity screening system using CYP3A4-expressing and γ-glutamylcysteine synthetase knockdown cells by Hosomi, Hiroko, Akai, Sho, Minami, Keiichi, Yoshikawa, Yukitaka, Fukami, Tatsuki, Nakajima, Miki, Yokoi, Tsuyoshi

    Published in Toxicology in vitro (01-04-2010)
    “…Drug-induced hepatotoxicity is often caused by CYP-dependent activation of the drugs into reactive metabolites. CYP3A4 is one of the main isoforms involved in…”
    Get full text
    Journal Article
  8. 8
  9. 9

    An in vitro drug-induced hepatotoxicity screening system using CYP3A4-expressing and I[sup3-glutamylcysteine synthetase knockdown cells by Hosomi, Hiroko, Akai, Sho, Minami, Keiichi, Yoshikawa, Yukitaka, Fukami, Tatsuki, Nakajima, Miki, Yokoi, Tsuyoshi

    Published in Toxicology in vitro (01-04-2010)
    “…Drug-induced hepatotoxicity is often caused by CYP-dependent activation of the drugs into reactive metabolites. CYP3A4 is one of the main isoforms involved in…”
    Get full text
    Journal Article
  10. 10

    Effect of antigen-dependent clearance on pharmacokinetics of anti-heparin-binding EGF-like growth factor (HB-EGF) monoclonal antibody by Kasai, Noriyuki, Yoshikawa, Yukitaka, Enokizono, Junichi

    Published in mAbs (03-09-2014)
    “…Heparin-binding EGF-like growth factor (HB-EGF) is a member of the EGF family and is an important therapeutic target in some types of human cancers. KM3566 is…”
    Get full text
    Report